Pancreatic Cancer Research

ResearcherUniversity of Pittsburgh Medical CenterNo recent work listed

Mitchell E. Tublin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8944-238X; OpenAlex author ID A5049901757. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper

Papers 1

  1. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2214/ajr.19.21152↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Melissa Ellen Hogg · 1 shared paper, 2020 · strength 0.10
  2. Amer H. Zureikat · 1 shared paper, 2020 · strength 0.10
  3. Herbert J. Zeh · 1 shared paper, 2020 · strength 0.10
  4. Nathan Bahary · 1 shared paper, 2020 · strength 0.10
  5. Brian A. Boone · 1 shared paper, 2020 · strength 0.10
  6. Michael T. Lotze · 1 shared paper, 2020 · strength 0.10
  7. Amir Ali Borhani · 1 shared paper, 2020 · strength 0.10
  8. Aatur Dilip Singhi · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.